This report, the first of two, arose from a one-week workshop directed at discussing concepts of immune regulation, and focuses on immunological tolerance. We first outline the major ideas we thought sufficiently plausible to provide a context for discussing more controversial issues around tolerance. We then report on our discussion of different experiments that appear paradoxical in terms of the different, contemporary models of CD4 T cell inactivation/ activation, and how such observations might be resolved in terms of insights provided by these contemporary models. These discussions bear on the plausibility of the Pathogen-Associated Molecular Pattern (PAMP), Danger and Two Step, Two Signal Models for the activation of na€ ıve CD4 T cells. Some of the observations considered appear paradoxical in terms of the PAMP and Danger Models, but not with the Two Step, Two Signal Model. For example, genetically immunodeficient mice have been given foreign, sterile ectopic grafts, and the immune system allowed to develop once these grafts were well-healed in, and so in the absence of PAMPs or danger. The grafts were rejected, unexpected on the PAMP or Danger Models. We also discussed considerations and observations bearing on the widely held idea that antigen must crosslink the membrane Ig receptors of a B cell to initiate the generation of signal 1, or the alternative possibility that monovalent binding by antigen can do so. We favored the latter possibility, and discussed a particular model, "the Elbow Model," for how this might be achieved.
The workshop's goals
A one-week workshop, directed at discussing concepts of how immune responses are regulated, was held in the south of Switzerland in June, 2016. The seven participants came together because they felt such discussions are of great interest and of potential significance. Such discussions can facilitate the progress of basic immunological research and its application to prevent or treat medical problems. The participants had read a recently published book [1] on the topic of the workshop. This provided a common starting point for agreement or disagreement in the discussions.
The prime aim of this report is to engage the reader to join our struggle for clarity, by reporting our considerations in a manner accessible to a broad readership. Our report is therefore cast in a way we hope is understandable to an undergraduate who has had an introduction to the subject and at the same time is thought provoking for the expert. We focused on two primary topics: firstly, how are immune responses regulated to simultaneously optimize the generation of beneficial immune responses and to minimize the generation of debilitating immune responses, such as those responsible for autoimmunity? This is the subject of this report. Secondly, what is the significance of the existence of distinct classes of immunity, their differential regulation, and how is such differential regulation achieved? This will be the subject of a second report.
We attempt to catch in this report the flavour of two aspects of our discussions as we roamed over these two broad topics. Firstly, we often veered off from discussing basic mechanisms to consider how knowledge of such mechanisms might impact strategies of clinical intervention. Secondly, the emphasis was not so much on achieving agreement but to seek clarification of the issues through discussion and references to the literature. We also sought to bring to the fore for discussion experimental papers whose significance we thought was insufficiently reflected in contemporary thinking. We were thus more motivated to achieve clarification than to formulate indubitable propositions. Lastly, we identified basic and clinical areas where we thought further discussion might be particularly valuable in the future. We are planning a follow-up meeting next year.
Central and peripheral tolerance
The conceptual framework for our considerations
The idea of central tolerance Burnet and Fenner proposed in 1949 that the property of self-antigens, that the immune system relies upon to distinguish them from foreign antigens, was their early appearance in development [2] . The observations of Medawar and Hasek and colleagues in the early 1950s were accepted, by the main contributors to the formulation of the clonal selection theory (Burnet, Jerne, Lederberg, and Talmage), as supporting Burnet and Fenner's proposal. Lederberg in his 1959 articulation of the clonal selection theory made two additional suggestions [3] . He proposed that clonal precursor cells, with receptors able to recognize diverse antigens, including self-antigens, are generated throughout life. This proposal could more readily account for the appearance of autoimmunity in later life than Burnet and Fenner's proposal, and led Lederberg to therefore propose that the ablation of the ability to generate anti-self-reactivity, or the inhibition of anti-selfresponses, required the early appearance in ontogeny of the self-antigens and their sustained presence thereafter, that is in the life history of the animal. Experimental observations support this proposal, which is conveniently referred to as the historical postulate. Lederberg's second innovative postulate constituted a proposal as to how the historical postulate might be realized at the cellular level. He proposed that when a cell has assembled genes able to code for a functional antibody molecule/antibody receptor, and when this cell first expresses this antibody receptor on its external membrane, this precursor cell may interact with its corresponding antigen to receive a signal. Lederberg proposed that this signal would kill or silence this cell. In contrast, this precursor cell, if it did not interact with its antigen when first generated, was postulated to have an internal clock, causing the cell after some time to differentiate into a new state. This newly differentiated cell was envisaged to bear identical antibody receptors as the cell from which it arose, but it was proposed that, on interacting with antigen, this cell was activated to divide and its progeny differentiates into antibody-producing cells and memory precursor cells. Such purging by antigen of anti-self-lymphocytes in the organ where these lymphocytes are generated is called central tolerance. A key distinction between the Burnet and Lederberg proposals, seen in a modern context and as discussed in more detail later, is that the presence of an antigen in early life is sufficient to induce tolerance according to Burnet, while in Lederberg's model an antigen present in early life would not induce tolerance unless it reaches the primary lymphoid organs where lymphocytes are generated.
The single lymphocyte/multiple lymphocyte model for the inactivation/activation of mature lymphocytes and peripheral tolerance
Another well-known model for how self-tolerance is achieved was proposed in 1970 [4] , and was formulated in the then accepted context, distinct from that envisaged by Lederberg, that mature lymphocytes, present in lymph nodes, spleen and in the circulation, can interact in two ways with antigen [5] , one way leading to their inactivation (death/silencing) and another way leading to their activation (multiplication and differentiation of their progeny into effector cells, such as antibody-producing cells). The interaction of antigen with the antigen-specific receptor of a lymphocyte was envisaged to generate a signal, signal 1 that, when generated alone for a sustained time, resulted in the inactivation of the lymphocyte. A target lymphocyte could be activated by antigen if a helper lymphocyte also recognized this antigen, a recognition leading in the delivery of another signal, signal 2, to the target lymphocyte. This two signal model of lymphocyte activation explained how self-tolerance might be achieved in a manner consistent with the historical postulate. Lymphocytes specific for a self-antigen were envisaged to be inactivated as they are generated, one or a few at a time, resulting in the ablation of an ability to respond to this antigen. In contrast, lymphocytes generated with antibody receptors only able to recognize a foreign antigen would accumulate in the absence of this foreign antigen. When this foreign antigen impacts upon the immune system, it would mediate the interaction between the accumulated lymphocytes necessary to activate them [3] . For reasons spelled out in the next section, this model of how mature anti-self-lymphocytes are activated or eliminated is now regarded as a model for how peripheral tolerance may be realized.
Multiple mechanisms for achieving self-tolerance
We have learnt, in the last five decades, to appreciate that there is not one but a series of mechanisms contributing to self-tolerance, rather as an onion consists of several layers. Our discussions concerning tolerance took place in a framework that can be encapsulated by six generalizations. These generalizations recognize this multilevel control of immune reactivity against self. These generalizations were for the most part accepted by workshop participants and were not the subject of extensive discussion. 6) Four major proposals have been made as to how antigen interacts differently with na€ ıve CD4 T cells to result in their activation or inactivation. The first three proposals we discuss share the basic idea that two signals are required to activate na€ ıve CD4 T cells, and signal one alone, without the critical second signal, inactivates lymphocytes. We discuss these three models before the fourth model. The fourth model proposes a different mechanism for the inactivation of lymphocytes. According to the first three models, signal 1 is generated when T cell receptors (TcR) bind their peptide/class II MHC complex. Signal two in all three models is generated when an APC (antigen presenting cell) not only presents antigen but bears the appropriate costimulatory molecules, that are recognized by counter receptors on the CD4 T cell, to generate a critical costimulatory signal, the critical second signal, required to activate the naïve CD4 T cell.
These three models differ in their proposals as to what controls the expression of the critical APC costimulatory molecules required to activate the CD4 T cells. These models are somewhat similar at a mechanistic level, but are correctly regarded by their proponents as having very different physiological/pathological consequences. It is perhaps also helpful to point out, ahead of considering the different models, that there are quite a few molecularly distinct pairs of costimulatory molecules on APC and their counter receptors on CD4 T cells. Moreover, these different costimulatory molecules are often differently expressed by different types of APC (dendritic cells, macrophages and B cells); in addition, their expression often depends upon the state of activation of the APC and how this activation is achieved. In addition, the expression of the receptor on the T cell recognizing these different costimulatory molecules often depends upon the activation state of the T cell. Thus, most of the discussion is best cast at this stage of our knowledge in terms of the word 'costimulatory system' in a generic sense, without defining molecularly which pair, or pairs, of costimulatory molecules and their receptors might be involved. There are insufficient pertinent observations to argue persuasively for roles of particular costimulatory systems. The PAMP model for the activation of CD4 T cells. Charles Janeway in 1989 proposed a new model for the activation of CD4 T helper cells [7] . He reviewed the evidence that had accumulated in the almost twenty years since the two signal model of lymphocyte activation was proposed and argued that such evidence supported this two signal model in the context of the inactivation and activation of B cells and CD8 T cells. He therefore argued that understanding the activation of CD4 T helper cells was critical to understanding how (virtually all) immune responses are initiated. Janeway pointed out that microbes are highly immunogenic when they infect a host, whereas many classical studies, employing highly purified proteins of non-microbial origin, usually require the use of adjuvants to generate robust immune responses. The most effective adjuvants contain microbial products, a requirement not taken into account by immunologists when formulating their concepts of how the immune system functions. Janeway famously referred to this fact as 'the immunologists' dirty little secret', referring, for example, to the dead mycobacteria that are present in complete Freund's adjuvant, as dirt. These mycobacteria, or other microbial products, he argued, are needed to generate robust immune responses. He proposed, using more modern terminology, that a pathogen-associated molecular pattern (i.e. a PAMP such as LPS) had to interact with a pattern recognition receptor (PRR) to result in an APC expressing a sufficient level of the critical costimulatory molecules required to activate naïve CD4 T cells. He proposed that in the absence of PAMPs, antigen would inactivate the CD4 T cell. We refer to Janeway's model as the PAMP model. He thus suggested that, at the level of CD4 T cells, the immune system distinguishes between infectious and non-infectious entities, rather than non-self from self, a proposal some might call radical.
The danger model for the activation of CD4 T cells. Polly Matzinger proposed in 1994 a different model [8] . She proposed, in her initial formulation, that the expression of the critical costimulatory molecules on APC, required for CD4 T cell activation, was upregulated under conditions of stress, a consequence of the body perceiving 'danger'. One reason for her proposal was that foreign grafts within a species were rejected. Such grafts were not expected to contain PAMPs, but the procedure of grafting surely involved stress. Matzinger appears, in more modern formulations, to suggest that 'danger signals' include the PAMP-generated signals envisaged by Janeway, as well as other stress signals. It seems that the PAMP and the danger models are currently the most favoured models.
The two step, two signal model for the activation of CD4 T cells. The 1970 one lymphocyte/multiple lymphocyte model for the inactivation/activation of lymphocytes [4] was given in 1999 a more detailed formulation in the context of the activation of CD4 T cells [9] . It was originally proposed in 1970 that the activation of T cells requires T cell collaboration [4] . This more detailed model, the two step, two signal model, has three features that were important for the workshop discussion, see Fig. 1 . Firstly, the activation of a CD4 T cell is envisaged to occur in two steps, step one and step two.
Step one does not involve lymphocyte cooperation, although the CD4 T cell receives a costimulatory signal when it interacts with a macrophage or mature DC that presents antigen. The CD4 T cell multiplies in response to the two signals of step one, and its descendants die or become silenced if they do not complete step two. Thus, step one of the 1999 formulation corresponds to the CD4 T cell receiving just signal 1 in the 1970 one lymphocyte/multiple lymphocyte model for the inactivation/ activation of lymphocytes.
The reasons for postulating this first step were on the basis of observations that na€ ıve CD4 T cells multiply in response to antigen presented by DC and macrophages, and because this step helps to overcome a perceived problem of the one lymphocyte/multiple lymphocyte model for the activation/inactivation of lymphocytes. Thus, it was recognized that antigen-specific lymphocytes are scarce in unprimed animals, and the postulate that lymphocyte cooperation is required to initiate lymphocyte activation led to the question of how could such scarce lymphocytes find each other? The multiplication of lymphocytes in step one was envisaged to help overcome this scarcity problem.
Secondly, step two again involves the target, step oneprimed CD4 T cell receiving two signals as it interacts with an activated B cell presenting the antigen. The costimulatory signals involved in step one and in step two are different from one another. The B cell is specific for the nominal antigen and must be activated by another antigenspecific CD4 T cell that recognizes antigen presented by this B cell if the B cell is to express the costimulatory molecules required to generate the costimulatory signal of step 2.
Thirdly, this two step, two signal model provides an explanation of peripheral tolerance at the level of CD4 T cells as a single CD4 T cell will only go through step one, and lymphocyte collaboration is required to complete step two. Thus, the model provides a mechanism of peripheral self/non-self discrimination, consistent with the historical postulate, in a manner similar to the one lymphocyte/ multiple lymphocytes model for the inactivation/activation of lymphocytes.
The postulate that the APC in step two is an antigenspecific B cell was made for two reasons. It was known that the activation of CD4 T cells specific for a nominal antigen Q could be facilitated by activated CD4 T cells specific for R, an antigen chosen not to cross react with Q, in the presence of the conjugate Q-R, but not in the presence of both Q and R as uncoupled antigens [6] . This requirement for linkage explains why CD4 T cells specific for a foreign antigen F cannot help the activation of CD4 T cells specific for a non-cross-reacting peripheral antigen pS in the presence of both F and pS. This non-interference would seem to be important physiologically. Note that the B cell, mediating the interaction between Q-specific CD4 T cells and R-specific CD4 T cells, could be specific for either Q or R. Both B cells would take up the conjugate via their BcR and present Q-and R-derived peptides.
The co-inhibitory model for lymphocyte inactivation. The fourth model for lymphocyte activation/inactivation, initially formulated by Nick Sinclair, is less specific about what is required to activate a lymphocyte and in this sense could be regarded, in contemporary terms, as consistent with any or any combination of the three activation models described above, but this model proposes a different mechanism for lymphocyte inactivation [10] . It was originally proposed, based upon studies on how antibody/antigen complexes exert potent feedback inhibitory signals on the activation of B cells, that the combination of B cell receptor (BcR) engagement/ signalling and Fc receptor engagement/signalling is the potent inactivating/inhibitory signal and not signal 1 alone. We refer to this model as the co-inhibitory model for lymphocyte inactivation/inhibition. There can be and are different co-inhibitory systems than that involving Fc receptors.
This model is of contemporary interest in two contexts. Firstly, it seems that this general type of model fits in with feedback regulation on the activation of B cells and T cells. In the case of B cells, the inhibitory signal requires signalling through both the BcR and a co-inhibitor such as the Fc receptor or CD22. In the case of T cells, feedback inhibitory signals can be mediated by a TcR signal and by a co-inhibitor such as CTLA-4 or by PD1 present on activated T cells. The disruption of such signalling is a central strategy of contemporary trials of immunotherapy of cancer that are causing considerable excitement. The second context in which the model might be of contemporary pertinence is in the inactivation of na€ ıve lymphocytes. This would mean, if valid, that in the case of CD4 T cells, the APC not only presents the antigen and expresses costimulatory molecules required for activation, but also expresses co-inhibitory molecules required for inactivation. There are few studies attempting to distinguish between a signal 1 mechanism and a co-inhibitory mechanism for the inactivation of CD4 T cells. There was little discussion as to the relative plausibility of the two models of lymphocyte inactivation. We thought this might be an important basic topic for the next workshop.
The discussion on peripheral tolerance
Models for the activation/inactivation of CD4 T cells
Some of us, other than Colin Anderson, proposed we start off with a discussion of one of his papers designed to test some basic ideas on how beneficial immune responses are generated and detrimental immune responses avoided [11, 12] . The primary aim of this study, designed and carried out by Anderson when in Polly Matzinger's lab, was to test predictions of the danger hypothesis. We started the discussion with this paper, and follow-up papers, as the studies reported were designed to test some very general ideas concerning peripheral tolerance. It appeared to us that the potential significance of these studies is neither broadly known nor discussed. The nature of the most important experiments and the conclusions they lead to are outlined in Fig. 2 . The upper half of the figure refers to the first experiments described. The first experiment by Anderson et al. In some experiments, lymphocyte-deficient (nude or RAGÀ/À) female mice were grafted with syngeneic male skin and, at various times after grafting, the mice were immunologically reconstituted (with wild-type thymic epithelial cells or foetal liver stem cells for nude and RAGÀ/À recipients, respectively). The immune system would thus be generated de novo in the presence of the pre-existing male skin graft. If generation took place before the graft had properly healed, when not well healed in, it was envisaged danger would be present at the graft site, and rejection should take place; if well healed in, danger should not be present, the graft should be accepted and tolerance towards the male antigen, H-Y, should be established. Four main conclusions were drawn from the observations made: Conclusion 1. It was found that whether well-healed skin grafts were accepted or rejected depended upon whether the male skin grafts came from wild-type or T lymphocyte-deficient (nude or RAGÀ/À) donors. If coming from wild-type donors, tolerance was established in the case of well-healed grafts, but if the grafts were from immunodeficient (nude or RAGÀ/À) donors, wellhealed grafts were rejected. It is essential to understand ........................................................................................................................................................... .... why these differences occur if the significance of these observations is to be assessed.
It was found that female mice, grafted with skin from wild-type male mice, had in their circulation male (passenger) lymphocytes some months after skin grafting. Evidence shows mature lymphocytes circulate to the thymus. Thus, male lymphocytes are present in the thymus of female mice with healed-in grafts and these lymphocytes can cause central tolerance to the male antigen in the female mice when their immune system develops. The importance of passenger lymphocytes in the male graft, to establish this tolerance, is demonstrated by the observation that skin from a male RAGÀ/À or nude mouse is rejected even when well healed prior to reconstitution [11, 12] . These observations seem to show that central tolerance is established when skin grafts come from wild-type male mice, but that tolerance is not established against male skin grafts from RAGÀ/À or nude donors in immunodeficient recipient females when the immune system develops in the presence of skin grafts. These observations lead to the first conclusion: the tolerance observed with healed-in grafts from lymphocyte-containing grafts is due to central tolerance.
Conclusion 2. The lack of tolerance in mice reconstituted in the presence of healed-in grafts, not containing passenger lymphocytes, appears at face value to contradict expectations held in the context of the danger hypothesis.
Conclusion 3. These results also appear to contradict the historical postulate as embodied in Burnet's and Bretscher and Cohn's models. It would be expected that, as the skin grafts are present before any competent lymphocyte is generated, self-tolerance would be established to the male antigen, which was clearly not always the case.
Conclusion 4. We appear to face paradoxes whichever way we turn as we try to understand the basis of peripheral tolerance. Indeed, the fourth and very significant conclusion would appear to be that the observations are fully consistent with Lederberg's vision of the historical postulate as the primary means to determine what antigens will induce tolerance and what antigens will induce immunity. Lederberg's view predicts that antigens induce immunity rather than tolerance even if they are present before immune system development if not present at the site where lymphocytes develop (i.e. in the thymus and bone marrow). Peripheral self-antigens, not present in primary lymphoid organs, would not induce tolerance even when present before development of immunocompetence.
Is there a mechanism of peripheral tolerance?. Conclusion 4 contradicts the proposal that a mechanism of peripheral tolerance exists. However, we have seen above, section 1c), subsection (v) , that the antigen-dependent inactivation of mature B cells and CD8 T cells is consistent with the one lymphocyte/multiple lymphocyte model for lymphocyte inactivation/activation. This model provides a mechanism of peripheral tolerance consistent with the historical postulate. This all seems a bit bewildering. Luckily, Anderson and his colleagues undertook further studies. These further studies are outlined in the bottom half of Fig. 2 and help, we think, to resolve issues.
The relationship of the one lymphocyte/multiple lymphocyte model to the historical postulate. Before discussing these further studies, it is helpful to clarify a point concerning the relationship of the one lymphocyte/multiple lymphocyte model to the historical postulate. The way in which the one lymphocyte/multiple lymphocyte model accounts for peripheral tolerance is envisaged to be effective given a certain rate of production and export of lymphocytes into the periphery following their generation in primary lymphoid organs. If this generation and export is substantially increased, or if the expansion of lymphocytes in the periphery is for some reason considerably larger than usual, the envisaged tolerance mechanism may fail to operate; if too many lymphocytes are generated specific for a peripheral self-antigen within a short period, they may not be silenced as generated, one or a few at a time. Thus, individuals with a mutation in AIRE generate and export from the thymus more non-regulatory CD4 T cells specific for peripheral self-antigens, such as insulin, than a normal individual, and autoimmunity ensues. These observations do not necessarily show that the one lymphocyte/multiple lymphocyte model for the inactivation/activation of lymphocytes is wrong. They may show that the envisaged mechanism fails under these unusual circumstances. Somewhat similarly, mice deficient in CTLA-4 are autoimmune. A central feedback mechanism on the multiplication of peripheral T cells is undermined in these mice, and so the occurrence of autoimmunity under these circumstances does not invalidate the idea that the model explains peripheral CD4 T cell tolerance under normal circumstances.
These observations and considerations provide a way out of the paradox that the skin graft experiments pose for the one lymphocyte/multiple lymphocyte model. It can be argued the H-Y antigen is so strong that too many lymphocytes are too rapidly generated for the one lymphocyte/multiple lymphocyte model to hold. This rate would have to exceed the rate typical for 'real' peripheral self-antigens, for which the model is envisaged to hold. However, this escape from the paradox seemed implausible at the time at which the male skin graft studies were reported. The male antigen is rather weak in the sense that it takes a few weeks for females to reject male skin grafts. It appeared at the time of these studies that the paradox could not be so easily dismissed. We shall see in the next section that this consideration is actually likely pertinent in making sense of the further experiments of Anderson and his colleagues.
The second paper by Anderson et al. The skin is not only full of micro-organisms, but is a rather special frontier. Anderson and his colleagues decided to do further experiments in a related system [13] . They decided to graft neonatal hearts or islets to a well-known ectopic site, under the kidney capsule, of immunodeficient female mice. They employed syngeneic male donors that bore the H-Y antigen or donors that differed from the immunodeficient (SCID or RAGÀ/À) female recipients at several minor histocompatibility loci. They employed either wild-type donors or lymphocyte-deficient donors as a source for the grafts. They found again that long-term grafts from wildtype donors were tolerant, and this was again associated with the establishment of lymphocyte chimerism. Interestingly, the male hearts or islets from lymphocytedeficient donors were not rejected and induced tolerance, independently of whether the hearts were or were not well healed in, although the well-healed group appeared more tolerant in some cases. However, the grafts with multiple minors, from lymphocyte-deficient donors, were in time often rejected, even when well healed in. Altogether, these observations demonstrate the importance of central tolerance and the limited capacity of peripheral tolerance mechanisms to act on tissues with multiple tissue restricted antigens, that is antigens not present or not sufficiently present in the thymus. These observations collectively appear to be more readily understood on the one lymphocyte/multiple lymphocyte model for the inactivation/ activation of CD4 T cells than on the danger model. It is also noteworthy that grafts with only one minor histoincompatibility difference, given post-immune reconstitution, were also accepted. Thus, such grafts, not well healed in, were not rejected, a finding difficult to reconcile with the danger model.
A role for context. It is interesting that male skin grafts but not male heart or islet grafts at an ectopic site are rejected. While rejection of the healed-in male RAGÀ/À skin graft is understandable in the context of Lederberg's model, tolerance of the male heart or islet graft from lymphocyte-deficient donors when transplanted to the ectopic site is not. It may be that the male skin grafts from lymphocyte-deficient donors are rejected as they are seen in a different 'context' (e.g. the local presence of skin flora) than hearts grafted under the kidney capsule. Thus, a 'dangerous context' may affect whether antigen activates or inactivates CD4 T cells. The context could influence the extent to which na€ ıve CD4 T cells multiply, thereby favouring activation over inactivation. The possibility that a dangerous context can sometimes influence whether CD4 T cell activation or inactivation occurs is different from the premise that danger is required for the activation of CD4 T cells. Matzinger has misrepresented these observations as supporting the danger model [14] .
The role of B cells and PAMPS in the activation of CD4 T cells
Janeway and colleagues published an interesting experimental study in 1991, two years after he elaborated upon his PAMP Theory. This experimental paper is not particularly well cited but appears to be central to understanding the requirements to activate antigen-specific CD4 T cells, including those specific for peripheral selfantigens. We therefore discussed this paper.
Janeway and colleagues found conditions in mice under which it was possible to activate mouse cytochrome cspecific CD4 T cells [15] . They first showed that immunization of H-2 k mice with human cytochrome c in CFA could result in the production of antibody, some of which bound uniquely to human cytochrome c, and some of which bound to both human and mouse cytochrome c, antibody we call the cross-reactive antibody, produced by cross-reactive B cells. Such immunization also gave rise to CD4 T cells specific for human cytochrome c, but it was not possible to detect any activated CD4 T cells specific for mouse cytochrome c following such immunization. Mouse cytochrome c-specific CD4 T cells could not be generated upon immunization with mouse cytochrome c administered in CFA, but immunization with both human and mouse cytochrome c administered together in CFA in exactly the same manner did result in the activation of mouse cytochrome c-specific CD4 T cells. Somehow, the presence of human cytochrome c allowed mouse-specific cytochrome c cells to be activated.
The critical events were further dissected by transfer studies. It was found that the transfer to na€ ıve mice, of B cells that cross react with human and mouse cytochrome c and generated upon immunizing with human cytochrome c, resulted in the activation of mouse cytochrome c-specific CD4 T cell when the recipient was immunized with a standard challenge of mouse cytochrome c alone administered in CFA. A series of compelling observations showed that these mouse cytochrome c-specific CD4 T cells did not cross react with human cytochrome c. In summary, these experiments show that there are 'na€ ıve' CD4 T cells in mice specific for mouse cytochrome c, but these CD4 T cells cannot be activated by immunizing with mouse cytochrome c given in CFA in the standard manner. This conclusion appears difficult to reconcile with the PAMP or danger models. Interestingly, the additional provision of activated B cells specific for mouse cytochrome c allowed these CD4 T cells to be activated, a finding consistent with the two step, two signal model. This eye-opener seems to be of crucial importance for the further discussion.
The participants of the workshop were aware of the diverse studies that have resulted in discordant observations on the obligatory role of B cells in the activation of CD4 T cells (reviewed in 6). The experimental system employed by Janeway and colleagues in this study is minimally manipulated, and the experiments were carried out before the use of various transgenic mice and knockout mice became so prevalent, so the observations may better reflect normal physiological processes. We also noted that treatment of cell-mediated, Th1 autoimmunity can be efficacious by depleting B cells. This efficacy may reflect a requirement for B cells in the sustained generation of Th1 responses. This study raises again the question of what is the role of microbial adjuvants in generating immune responses. We thought this would be valuable topic for discussion at next year's workshop.
No vote was taken on, or collective discussions directed at assessing, the overall plausibility of the four different models for the activation/inactivation of CD4 T cells. Discussions between individuals showed there to be no consensus.
How does the binding of antigen to the membrane Ig (mIg) of B cells initiate the generation of signal 1 that causes the inactivation of B cells? The elbow model
The sustained interaction of B cells with antigen alone, for about two days, results in B cell inactivation. The generation of signal 1, the mediating signal, is generally believed to be initiated when antigen causes the crosslinking of the B cell's mIg. We refer to this as the crosslinking model for initiating the generation of signal 1. We discussed the plausibility of a different model for initiating signal 1 on the basis of four grounds. We outline these grounds before providing more detailed considerations relevant to grounds (ii) and (iv). Signal 1 is also required for B cell activation. The crosslinking model would preclude the production of antibody to monomeric antigens, such as some toxins, another consideration against the cross-linking model.
In vivo observations on requirements for B cell inactivation
Classical observations suggest that monomeric (univalent) macromolecules can inactivate B cells. The experimental evidence for this is of two kinds. Firstly, experiments in the 1970s and later showed that monovalent macromolecules could inactivate B cells. For example, Goodnow and colleagues showed that monomeric hen egg lysozyme (HEL) could render anti-HEL B cells anergic [17] . It is not possible, in all these rather many in vivo experiments, to be sure that a small fraction of the antigen does not become aggregated and so is responsible for inactivating the B cell. This introduces some uncertainty. However, another class of observation further supports the idea that 'tolerance' at the B cell level can be almost complete, and this provides strong but indirect evidence that all peripheral antigens, independently of their uni-or multivalent nature, can inactivate B cells. Thus, immunization with foreign vertebrate cells or proteins can often result in the production of antibody to the immunizing antigen without the production of antibody to the corresponding selfantigen, although immunization of other species with the foreign and corresponding self-antigen shows these two antigens to cross react. The generality of this finding suggests B cell tolerance is remarkably complete. In some cases, however, it is possible to induce autoimmunity to a self-antigen by immunizing with a corresponding 'crossreactive' foreign, vertebrate antigen. A classic example is the immunization of rabbits with turkey thyroglobulin that results in the production of antibody to rabbit thyroglobulin. In this case, most envisage that rabbit thyroglobulin is at too low a level to cause complete B cell tolerance.
Structural considerations on how antigen binding to mIg might initiate signal transduction
The above considerations led us to consider whether monovalent binding of antigen to mIg could initiate signal transduction. This is obviously a critical point. If there were no mechanism that seems plausible, these considerations would have to be revisited and reassessed.
It is helpful to briefly recall what is known about how antibody, present in the blood in contrast to the situation where it is a membrane receptor, can signal its interaction with antigen. Studies in the 1960s examined how the binding of IgM and IgG antibody molecules to the surface of a cell could initiate the complement cascade resulting in the cell's lysis [18] . It was determined that the binding of one IgM molecule was sufficient to initiate this cascade. However, not every IgM molecule that bound to a red cell could do so. It seems likely that when one IgM molecule binds multivalently to different sites, the IgM molecule can become distorted, revealing 'distortion sites' inaccessible on the uncomplexed IgM molecule. The 'interaction recognition site' of complement can recognize and bind to these distortion sites, initiating the cascade.
Comparable studies with IgG antibody led to the conclusion that two, or a few, IgG molecules had to bind to neighbouring sites on the red cell surface in order to initiate the complement cascade. It was estimated in these studies that over a 100,000 IgG molecules had to bind to the red cell's surface in order that an initiating doublet or patch of IgG molecules is likely to occur. In this case, the preferential binding of the interaction recognition site of the initiating complement component with bound antibody is likely primarily due to the cooperation achieved by simultaneously binding to several IgG molecules held in place by their binding to the antigen. There is no evidence that soluble antibody can signal its interaction with antigen on binding monovalently to antigen.
The unlikelihood of allosteric, structural changes, on antigen binding monovalently to mIg, serving as a mechanism of initiating signal transduction A common means of signals being transmitted through proteins, on their binding to small or larger ligands, is referred to as allostery. We considered whether allosteric changes could initiate the generation of signal 1.
For clarity, we consider first the case of a small, haptenlike molecule that binds a given antibody molecule. Such binding may result in a structural change of the antibody. However, not all structural changes can be exploited to initiate a signal. The change, to be so exploited, must involve the non-variable part of the antibody; in this case, it can be recognized by an 'interaction recognition site' present on another molecule that is part of the signal transduction complex. This means that the same structural change must occur in the non-variable part of the Ig molecule when diverse antibodies bind to their diverse antigens. This would only seem plausible if all binding sites share some structural feature, which itself seems quite implausible. Allosteric changes can be very useful in providing a general means for regulating the activity of proteins, but such allosteric changes, seen in 'conventionally evolved' proteins, exist through the grace of evolution and are really difficult to envisage for antibodies. Antibody genes are assembled somatically to provide an incredible diversity of antigenbinding molecules. It seems difficult to imagine a selection process by which only those cells, whose antibodies are able to transmit a useful allosteric signal, survive.
The potential for monovalent binding of antigen to mIg to initiate signalling Are there then other ways that monovalent binding could plausibly lead to signal transduction? Consider a typical divalent antibody molecule. The two antigen-binding, Fab domains of an unbound antibody molecule point in opposite directions, so the overall shape of the molecule tends to resemble a 'T', the stem representing the Fc portion. Suppose in contrast the two Fabs were close together and aligned so that their combining sites were close together. The simultaneous monovalent binding of two macromolecules to these two neighbouring sites would not be possible without some structural change in the Ig molecule, including invariant parts of the Ig molecule. This example illustrates a potential means of signalling, following monovalent binding. It is unrealistic in this particular case as it does not reflect what is known about the overall structure of an unbound antibody molecule.
Yang and Reth suggest that mIg in resting B cells are clustered [16] . Such clustering might be in a manner that a Fab of one mIg molecule may be very close to a Fab of its neighbour. In this case, neighbouring mIg molecules, on both binding monovalently to sizable ligands, may only be able to do so following receptor disassociation that can initiate signalling. The structural changes would not reflect very specific interactions, as envisaged in allosteric interactions, but rather reflect larger-scale space needs. An everyday analogy might be a dinner party with a table for six, but eight guests appear. The guests are polite and so all are seated, but they must sit further from the table than if there were only six guests. We call this model the elbow model on the basis of this analogy.
The elbow model predicts that very small molecules cannot achieve mIg receptor disassociation and that a certain size of ligand is required to initiate signalling. The strongest prediction is that there is a one-to-one correspondence with antigen molecules able to cause receptor disassociation and with the ability to generate signal 1, and so inactivate the B cell.
A final point was considered. Borel has shown that mice are not tolerant at the B cell level to the monomeric component of complement known as C5 [19] . C5 is present in blood at the rather high level of about 50 lg/ml, corresponding to a concentration of about 2 9 10 À7 M, and so it might be anticipated, upon the elbow model of signal 1, that there would be tolerance towards C5 at the B cell level. It arose in discussion that C5 may be a somewhat special case. The argument drew a parallel with the rheumatoid factor, which is an antibody that recognizes epitopes uniquely present on complexed antibodies, and it can be raised by immunizing with foreign antigen/ antibody complexes. Presumably CD4 T cells, specific for the foreign antigen, allow B cells, specific for these epitopes on complexed antibody, to be activated to produce rheumatoid factor. Similarly, C5 may normally often exist complexed with foreign antigen, antibody and other components of complement. These circumstances might result in anti-C5 B cells receiving signal 2 from CD4 T helper cells specific for the foreign antigen, thus undermining the inactivation of the anti-C5 B cells.
Concluding remarks
We established that there were too many interesting topics to adequately discuss them all on this occasion. We left them for our next meeting(s). We hope that some dedicated readers might take interest in our meetings and eventually join them in the future. Individuals interested in joining us to discuss foundational concepts of the field are invited to contact Peter Bretscher, indicating the nature of their interest and evidence of this interest. We will, however, keep the number of participants to about ten individuals for organizational reasons and to foster intense discussions. Next year, we plan to discuss questions stemming from this and another report (manuscript in preparation) on the significance of the existence of distinct classes of immunity, their differential regulation and how such differential regulation is achieved.
